Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine.
BACKGROUND:Increases in pneumococcal meningitis were reported from Ghanaian regions that lie in the meningitis belt in 2016-2017, despite introduction of 13-valent pneumococcal conjugate vaccine (PCV13) in 2012 using a 3-dose schedule (6, 10, and 14 weeks). We describe pneumococcal meningitis epidem...
Main Authors: | Catherine H Bozio, Abass Abdul-Karim, John Abenyeri, Braimah Abubakari, Winfred Ofosu, Justina Zoya, Mahamoudou Ouattara, Velusamy Srinivasan, Jeni T Vuong, David Opare, Franklin Asiedu-Bekoe, Fernanda C Lessa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6128537?pdf=render |
Similar Items
-
Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-04-01) -
Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-03-01) -
Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-03-01) -
Corticosteroids in Pneumococcal Meningitis
by: J Gordon Millichap
Published: (1991-12-01) -
Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011-2018.
by: John Njuma Libwea, et al.
Published: (2021-01-01)